Investing News How Pfizer Emerged as the Winner in Bidding War for Global Blood Therapeuitcs August 24, 2022
Investing News Arrowhead Pharmaceuticals and Johnson & Johnson To Share Potentially Exciting News August 24, 2022
Investing News KalVista Hits Its Highest Point in Five Months, as Its Rival Drops Due to Hereditary Angioedema. August 22, 2022
Investing News To Increase Its Presence in Rare Hematology, Pfizer Will Purchase Global Blood Therapeutics for $5.4 Billion. August 8, 2022
Investing News Amgen Reduces Its Sales Forecast After Announcing Plans To Acquire ChemoCentryx August 5, 2022
Search
biopharmaceutical
August 29, 2022
August 25, 2022
August 24, 2022
August 24, 2022
August 22, 2022
August 12, 2022
August 8, 2022
August 5, 2022
August 5, 2022
August 4, 2022
